PPARα has proven effects in reducing body weight, serum lipids, and fasting glucose levels, improving insulin sensitivity, and preventing hepatic steatosis and NAFLD in animal models [14,20]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.